rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

James Patrick Tursi

Director

Company insider

Files Form 4 as: Director, MetaVia; Executive VP, Global R&D, Endo International; Director, Agile Therapeutics; EVP, Chief Medical Officer, Antares Pharma; Chief Medical Officer, Aralez Pharmaceuticals; Chief Medical Officer, Pozen Inc /nc; Chief Medical Officer, Auxilium Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
79
Buys
3
Sells
6
Bought
$65K
Sold
$3.0M
Companies
7
Companies where not an officer
2
First trade
8 Aug 2011
Last trade
8 Jun 2026
Last filed
8 Jun 2026

Companies traded

Where they are an officer
Endo InternationalOfficer · last 15 Jul 20220 buys · 0 sells
Antares PharmaOfficer · last 13 Jun 20190 buys · 0 sells
Aralez PharmaceuticalsOfficer · last 14 May 20183 buys · 3 sells
Pozen Inc /ncOfficer · last 1 Oct 20150 buys · 0 sells
Auxilium PharmaceuticalsOfficer · last 29 Jan 20150 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MTVA MetaViaDirector · Biotechnology · last 8 Jun 20260 buys · 0 sells
Agile TherapeuticsDirector · last 9 Jun 20220 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 8 Jun 2026MTVA MetaViaBiotechnologySEC FORM 4 Code A—17,186 at $0.00filing
8 Jun 2026filed 8 Jun 2026MTVA MetaViaBiotechnologySEC FORM 4 Code A—17,186 at $0.00filing
30 Jun 2025filed 1 Jul 2025MTVA MetaViaBiotechnologySEC FORM 4 Code A—28,147 at $0.00filing
7 Jun 2024filed 7 Jun 2024MTVA MetaViaBiotechnologySEC FORM 4 Code A—5,051 at $0.00filing
1 Dec 2023filed 4 Dec 2023MTVA MetaViaBiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
1 Dec 2023filed 4 Dec 2023MTVA MetaViaBiotechnologySEC FORM 4 Code A—7,157 at $0.00filing
15 Jul 2022filed 17 Aug 2022Endo InternationalSEC FORM 4 Code D—280,373filing
9 Jun 2022filed 10 Jun 2022Agile Therapeuticsoption or derivativeSEC FORM 4 Code A—807 at $0.00filing
9 Jun 2022filed 10 Jun 2022Agile TherapeuticsSEC FORM 4 Code A—670 at $0.00filing
8 Jun 2021filed 10 Jun 2021Agile TherapeuticsSEC FORM 4 Code A—24,510 at $0.00filing
8 Jun 2021filed 10 Jun 2021Agile Therapeuticsoption or derivativeSEC FORM 4 Code A—29,905 at $0.00filing
9 Jun 2020filed 11 Jun 2020Agile Therapeuticsoption or derivativeSEC FORM 4 Code A—22,606 at $0.00filing
9 Jun 2020filed 11 Jun 2020Agile TherapeuticsSEC FORM 4 Code A—13,393 at $0.00filing
13 Jun 2019filed 14 Jun 2019Antares Pharmaoption or derivativeSEC FORM 4 Code A—90,788 at $0.00filing
13 Jun 2019filed 14 Jun 2019Antares PharmaSEC FORM 4 Code A$132K45,205 at $2.92filing
6 Jun 2019filed 7 Jun 2019Agile Therapeuticsoption or derivativeSEC FORM 4 Code A—75,000 at $0.00filing
6 Aug 2018filed 7 Aug 2018Antares Pharmaoption or derivativeSEC FORM 4 Code A—150,000 at $0.00filing
8 Jun 2018filed 8 Jun 2018Agile TherapeuticsSEC FORM 4 Code M—17,949filing
8 Jun 2018filed 8 Jun 2018Agile Therapeuticsoption or derivativeSEC FORM 4 Code M—17,949 at $0.00filing
7 Jun 2018filed 8 Jun 2018Agile Therapeuticsoption or derivativeSEC FORM 4 Code A—50,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed9

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.